Antioxidative, Antinitrative, and Vasculoprotective Effects of a Peroxisome Proliferator-Activated Receptor- Agonist in Hypercholesterolemia

Circulation - United States
doi 10.1161/01.cir.0000097003.49585.5e
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Peroxisome Proliferator-Activated Receptor

English

Peroxisome Proliferator Activated Receptor

English

A Peroxisome Proliferator-Activated Receptor-Gamma Agonist and Other Constituents fromChromolaena Odorata

Planta Medica
Organic ChemistryMolecular MedicinePharmacologyComplementaryPharmaceutical ScienceAnalytical ChemistryAlternative MedicineDrug Discovery
2009English

Effects of Peroxisome Proliferator-Activated Receptor-Δ Agonist on Cardiac Healing After Myocardial Infarction

PLoS ONE
Multidisciplinary
2016English

Peroxisome Proliferator-Activated Receptor Γ-Mediated Differentiation

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2003English

Peroxisome Proliferator-Activated Receptor-Γ (PPARG; PPARγ)

Science-Business eXchange
2009English

The Peroxisome Proliferator–Activated Receptor Β/Δ Agonist GW0742 Has Direct Protective Effects on Right Heart Hypertrophy

Pulmonary Circulation
PulmonaryRespiratory Medicine
2013English

Renoprotective and Haemodynamic Effects of Adiponectin and Peroxisome Proliferator-Activated Receptor Agonist, Pioglitazone, in Renal Vasculature of Diabetic Spontaneously Hypertensive Rats

2020English

Peroxisome Proliferator-Activated Receptor Γ Agonist Rosiglitazone Increases Expression of Very Low Density Lipoprotein Receptor Gene in Adipocytes

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy